| Financial Year |
March 31 2023 |
| Monetary Funds |
670,742,214.86 |
| Held-for-trading Financial Assets |
128,800.00 |
| Notes Receivable |
16,623,877.21 |
| Accounts Receivable |
369,616,869.36 |
| Advances to Suppliers |
28,720,237.55 |
| Other Receivables |
31,950,799.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,104,454,769.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,083,127.55 |
| Total Current Assets |
2,380,508,890.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,216,843.35 |
| Investment Properties |
-- |
| Fixed Assetes |
2,995,451,690.59 |
| Under-construction Projects |
146,162,501.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
250,982,875.02 |
| R&D expenses |
176,329,438.37 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,765,349.31 |
| Deferred Income Tax Assets |
39,278,006.08 |
| Other Non-Current Assets |
325,579,533.91 |
| Sub-Total of Non-Current Assets |
4,240,767,497.95 |
| Total Assets |
6,621,276,388.42 |
| Short-Term Loans |
539,366,424.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
186,578,275.00 |
| Accounts Payable |
615,368,995.14 |
| Accounts Received In Advance |
569,478.19 |
| Employee Compensation Payable |
43,292,714.07 |
| Taxes Payable |
37,057,398.06 |
| Interest Payable |
-- |
| Dividend Payable |
128,206.38 |
| Other payables |
331,074,726.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
297,220,849.13 |
| Other Current Liabilities |
12,198,202.99 |
| Sub-Total of Current Liabilities |
2,170,001,614.29 |
| Long-term Loans |
439,483,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
39,245,238.16 |
| Other Non-Current Liabilities |
1,008,224.00 |
| Sub-Total of Non-Current Liabilities |
608,279,320.62 |
| Total Liabilities |
2,778,280,934.91 |
| Paid-In Capital(Or Share Stock) |
1,096,242,680.00 |
| Capital Surplus |
326,946,079.52 |
| Surplus Reserve |
233,404,335.71 |
| LESS:Treasury Stock |
10,062,360.00 |
| Undistributed Profits |
1,223,111,828.03 |
| Minority Stockholder's Interest |
800,479,702.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,042,515,751.08 |
| Owner's Equity（Stockholder's Equity） |
3,842,995,453.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,621,276,388.42 |
